Home > News > Nano-Particle Cancer Therapeutic for NCI-sponsored Clinical Trial
September 12th, 2005
Nano-Particle Cancer Therapeutic for NCI-sponsored Clinical Trial
Abstract:
CytImmune Sciences, Inc., a clinical stage nano-biotechnology company focused on the delivery of therapeutics, today announced that it would enter into production of its first tumor-targeting biotherapeutic for an upcoming clinical trial sponsored by the National Cancer Institute.
Source:
pharmalive.com
Related News Press |
Possible Futures
Closing the gaps — MXene-coating filters can enhance performance and reusability February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
Nanomedicine
Multiphoton polymerization: A promising technology for precision medicine February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
SMART researchers pioneer first-of-its-kind nanosensor for real-time iron detection in plants February 28th, 2025
Announcements
Closing the gaps — MXene-coating filters can enhance performance and reusability February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |